Equillium Inc (EQ)
1.57
+0.03
(+1.95%)
USD |
NASDAQ |
May 17, 16:00
1.57
0.00 (0.00%)
After-Hours: 20:00
Equillium Cash from Investing (Quarterly): -2.831M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -2.831M |
December 31, 2023 | -5.566M |
September 30, 2023 | 10.98M |
June 30, 2023 | 15.00M |
March 31, 2023 | -25.18M |
December 31, 2022 | 6.978M |
September 30, 2022 | 15.00M |
June 30, 2022 | 8.691M |
March 31, 2022 | -11.98M |
December 31, 2021 | -16.89M |
September 30, 2021 | 10.47M |
June 30, 2021 | 28.97M |
March 31, 2021 | 4.86M |
Date | Value |
---|---|
December 31, 2020 | -17.04M |
September 30, 2020 | -23.02M |
June 30, 2020 | 8.455M |
March 31, 2020 | 13.00M |
December 31, 2019 | -5.33M |
September 30, 2019 | -0.225M |
June 30, 2019 | 6.04M |
March 31, 2019 | -2.651M |
December 31, 2018 | -37.41M |
September 30, 2018 | -0.003M |
June 30, 2018 | -0.017M |
March 31, 2018 | -0.005M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-25.18M
Minimum
Mar 2023
28.97M
Maximum
Jun 2021
1.020M
Average
5.45M
Median
Cash from Investing (Quarterly) Benchmarks
Janux Therapeutics Inc | -113.74M |
Mersana Therapeutics Inc | -72.55M |
Vera Therapeutics Inc | -219.29M |
NovaBay Pharmaceuticals Inc | 1.068M |
Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -8.80M |
Free Cash Flow | -22.66M |
Free Cash Flow Per Share (Quarterly) | -0.2502 |
Free Cash Flow to Equity (Quarterly) | -8.819M |
Free Cash Flow to Firm (Quarterly) | -8.819M |
Free Cash Flow Yield | -41.57% |